Epilepsy in Children and Youth: Advanced Program

Young husband and wife with their young daughter of 3 years-old

This series builds on the foundational curriculum and aims to develop proficiency in the management of epilepsy.

OCTOBER 17 - NOVEMBER 28, 2024 | 12:00 PM - 1:00 PM EST | THURSDAYS WEEKLY

Register

This program explores a range of complex topics such as drug resistant epilepsy, polypharmacy, genetics, ketogenic diet, and more. This program is intended for clinicians who are seeking to further their competencies in epileptology.

  • Next Session

    October 17, 2024

    12:00 pm 1:00 pm

    S1. Polypharmacy

Case Support - supporting you and your patient graphic

Case Support

Healthcare providers can present your de-identified case for advice, support and written recommendations.

Submit a Case

This series is facilitated by McMaster Children’s Hospital.

McMaster Children's Hospital Logo

Syllabus

This Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up for up to 1.0 Mainpro+ credits.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 1.0 hours.

  • Identify evidence-supported indications and dosing
  • Recognize common drug-drug interactions and side effects
  • Recognize epilepsy can be a genetic condition
  • Identify patients with epilepsy that may benefit from genetic testing
  • Describe the process of genetic testing for epilepsy in Ontario
  • Describe the underlying mechanism of the ketogenic diet
  • Identify how the diet is monitored in children with epilepsy
  • Recognize clinical considerations for ketogenic diet as a treatment option for children living with epilepsy
  • Identify the evidence-supported indications and dosing for cannabinoid therapy in epilepsy
  • Recognize common drug-drug interactions, side effects, and practical considerations in using cannabinoids in pediatric epilepsy
  • Describe the ways in which healthcare professionals can support and facilitate families in accessing medical cannabis
  • Identify drug resistant epilepsy (DRE)
  • Recognize when to refer to a paediatric epilepsy program, referral pathways available in Ontario
  • Describe the importance of counseling regarding DRE
  • Recognize issues that may arise as children with epilepsy become teenagers including contraception and pregnancy, driving, and mood disorders
  • Identify the risk factors for SUDEP, current preventative measures, and the importance of counselling patients and families
  • Recognize factors impacting health care transition for youth with epilepsy
  • Identify the most common psychiatry and somatic co-morbidities associated to epilepsy
  • Discuss the management of the common psychiatric and somatic co-morbidities associated with epilepsy

Didactics & Recordings

*Available after sessions begin


You must be logged in to view this content.

Clinical Leads

Dr. Kevin Jones

Dr. Kevin Jones, Paediatric Neurologist & Epileptologist

Medical Co-Lead

Dr. Robyn Whitney

Dr. Robyn Whitney, Paediatric Neurologist & Epileptologist

Medical Co-Lead

Dr. Rajesh Ramachandrannair

Dr. Rajesh Ramachandran Nair, Paediatric Neurologist & Epileptologist

Medical Co-Lead

Cynthia Sloan Birbeck, Nurse Practitioner

Cynthia Sloan Birbeck, Nurse Practitioner

Leah Morgenstern, Registered Nurse

Leah Morgenstern, Registered Nurse

Trevor Dalton, Psychometrist

Trevor Dalton, Psychometrist

Female icon

Nevena Simic, Clinical Neuropsychologist

Female icon

Kristin Welton, Community Epilepsy Agency Navigator

Epilepsy Niagara

Register